Cancer Cell Biology

You have full text access to this OnlineOpen article

Human agmatinase is diminished in the clear cell type of renal cell carcinoma

  1. Kerstin Dallmann1,
  2. Heike Junker1,
  3. Stefan Balabanov1,†,
  4. Uwe Zimmermann2,
  5. Jürgen Giebel3,
  6. Reinhard Walther1,‡,*

Article first published online: 28 OCT 2003

DOI: 10.1002/ijc.11459

Issue

International Journal of Cancer

International Journal of Cancer

Volume 108, Issue 3, pages 342–347, 20 January 2004

Additional Information

How to Cite

Dallmann, K., Junker, H., Balabanov, S., Zimmermann, U., Giebel, J. and Walther, R. (2004), Human agmatinase is diminished in the clear cell type of renal cell carcinoma. Int. J. Cancer, 108: 342–347. doi: 10.1002/ijc.11459

Author Information

  1. 1

    Department of Medical Biochemistry and Molecular Biology, University of Greifswald, Greifswald, Germany

  2. 2

    Department of Urology, University of Greifswald, Greifswald, Germany

  3. 3

    Department of Anatomy, University of Greifswald, Greifswald, Germany

  1. †

    Department of Hematology/Oncology, University of Tübingen, D-72076 Tübingen, Germany

  1. ‡

    Fax: +49-3834-865402

*Institut für Medizinische Biochemie und Molekularbiologie, Ernst-Moritz-Arndt-Universität, Klinikum/F.-Sauerbruchstrasse, D-17487 Greifswald, Germany

Publication History

  1. Issue published online: 21 NOV 2003
  2. Article first published online: 28 OCT 2003
  3. Manuscript Accepted: 4 JUL 2003
  4. Manuscript Revised: 12 JUN 2003
  5. Manuscript Received: 9 JAN 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (299K)

REFERENCES

  • 1
    Ahn YS, Zerban H, Bannasch P. Expression of glucose transporter isoforms (GLUT1, GLUT2) and activities of hexokinase, pyruvate kinase, and malic enzyme in preneoplastic and neoplastic rat renal basophilic cell lesions. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 63: 351–7.
  • 2
    Steinberg P, Storkel S, Oesch F, Thoenes W. Carbohydrate metabolism in human renal clear cell carcinomas. Lab Invest 1992; 67: 506–11.
  • 3
    Kovacs G. Molecular genetics and diagnosis of renal cell tumors. Urologe A 1999; 38: 433–41.
  • 4
    Balabanov S, Zimmermann U, Protzel C, Scharf C, Klebingat KJ, Walther R. Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur J Biochem 2001; 268: 5977–80.
    Direct Link:
  • 5
    Mistry SK, Burwell TJ, Chambers RM, Rudolph-Owen L, Spaltmann F, Cook WJ, Morris SM Jr. Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus. Am J Physiol 2002; 282: 375–81
  • 6
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.
  • 7
    Hessabi B, Ziegler P, Schmidt I, Röpke C, Walther R. The nuclear localization signal (NLS) of PDX-1 is part of the homeo-domain and represents a novel type of NLS. Eur J Biochem 1999; 263: 170–7.
    Direct Link:
  • 8
    Morris SM Jr, Bhamidipati D, Kepka-Lenhardt D. Human type II arginase: sequence analysis and tissue-specific expression. Gene 1997; 193: 157–61.
  • 9
    Colleluori DM, Morris SM Jr, Ash DE. Expression, purification and characterization of human type II arginase. Arch Biochem Biophys 2001; 389: 135–43.
  • 10
    Iyer RK, Kim HK, Tsoa RW, Grody WW, Cederbaum SD. Cloning and characterization of human agmatinase. Mol Genet Metab 2002; 75: 209–18.
  • 11
    Sastre M, Galea E, Feinstein D, Reis DJ, Regunathan S. Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines. J Biochem 1998; 330: 1405–9.
  • 12
    Gokmen SS, Aygit AC, Ayhan MS, Yorulmaz F, Gulen S. Significance of arginase and ornithine in malignant tumors of the human skin. J Lab Clin Med 2001; 137: 340–4.
  • 13
    Wei LH, Wu G, Morris SM Jr, Ignarro LJ. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci USA 2001; 98: 9260–4.
  • 14
    Straus B, Cepelak I, Festa G. Arginase, a new marker of mammary carcinoma. Clin Chim Acta 1992; 210: 5–12.
  • 15
    Wu CW, Chung WW, Chi CW, Kao HL, Lui WY, P'eng FK, Wang SR. Immunohistochemical study of arginase in cancer of the stomach. Virchows Arch 1996; 428: 325–31.
  • 16
    Nieves C Jr, Langkamp-Henken B. Arginine and immunity: a unique perspective. Biomed Pharmacother 2002; 56: 471–82.
  • 17
    Tapiero H, Mathe G, Couvreur P, Tew KD. Arginine. Biomed Pharmacother 2002; 56: 439–45.
  • 18
    Chang Chiung-I, Liao JC, Kuo L. Macrophage arginase promotes tumor cell growth and suppress nitric oxide–mediated tumor cytotoxicity. Cancer Res 2001; 61: 1100–6.
  • 19
    Fukamura D, Jain RK. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 1998; 17: 77–89.
  • 20
    Morrissey JJ, Klahr S. Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians 1997; 109: 51–7.
  • 21
    Schwartz D, Peterson OW, Mendonca M, Satriano J, Lortie M, Blantz RC. Agmatine affects glomerular filtration via a nitric oxide synthase–dependent mechanism. Am J Physiol 1997; 272: 597–601.
  • 22
    Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ. Inhibition of mammalian nitric oxide synthesis by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996; 316: 247–9.
  • 23
    Galea E, Feinstein DL. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J 1999; 13: 2125–37.
View Full Article (HTML) Get PDF (299K)